The FDA has approved relacorilant (Lifyorli, Corcept Therapeutics) in combination with nab-paclitaxel for adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal ...
Join Drs Steven Feldman and Bernard Vrijens as they discuss the theory and practice of improving treatment adherence for ...
Amid mounting lawsuits against social media companies and mental health concerns, the question remains: Is social media addiction real?
Most clinicians take no preventive action when a low-risk patient presents with elevated levels of lipoprotein(a), but 1 in 5 ...
AI-based screening for glaucoma can be implemented in primary care within existing screening programmes, enhancing efficiency ...
Limited numeracy affects how patients interpret risk and treatment benefits, highlighting the need for clear, structured ...
A new study showed people who eat more than nine servings of ultraprocessed food every day are much more likely to suffer heart attacks and strokes or die from heart disease than those who eat less — ...
Minimally invasive olfactory brush biopsy flags biological signals of Alzheimer’s disease years before memory loss occurs.
METHODOLOGY: A prospective, open-label, single-arm study enrolled eight pediatric patients (62.5% female; median age, 16 years) with SLE who had MAS and had an inadequate response ...
From 19th century ‘white blood’ observations and pathological anatomy to the discovery of BCR-ABL and imatinib, leukemia care ...
Ministers launch GMC reform consultation, but doctors warn expanded appeal powers could increase delays and undermine trust.
A new analysis evaluates how acquisition prices, reimbursement prices, and adoption of oncology biosimilars have shifted.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results